Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
08/1995
08/30/1995EP0668877A1 Displacement chromatography process and purified hemoglobin product
08/30/1995EP0668876A1 Treatment of infertility and enhancement of fertilization capacity in mammalian males
08/30/1995EP0668875A1 Clot directed anticoagulant, process for making same and methods of use
08/30/1995EP0668874A1 Lhrh antagonists and intermediate products
08/30/1995EP0668873A1 Antagonists of human gamma interferon
08/30/1995EP0668872A1 Calcium channel blocking polypeptides from theraphosidae aphonopelma
08/30/1995EP0668871A1 Amino-acid sequence homologies between selectins and b. pertussis toxin-peptidesderived therfrom, antibodies thereto and pharmaceutical compositions
08/30/1995EP0668870A1 Inhibitors of picornavirus proteases
08/30/1995EP0668869A1 2- 3-(4-amidinophenyl)]propionic acid derivatives, their preparation and their use
08/30/1995EP0668868A1 Low allergenic proteins
08/30/1995EP0668856A1 Inhibitors of farnesyl-protein transferase
08/30/1995EP0668781A1 Lymphokine gene therapy of cancer
08/30/1995EP0668777A1 Prostate-specific membrane antigen
08/30/1995EP0668776A1 Method for design of substances that enhance memory and improve the qualilty of life
08/30/1995EP0668774A1 Interleukin receptor targeted molecules for treatment of inflammatory arthritis
08/30/1995EP0668773A1 Improved fish production
08/30/1995EP0668772A1 Specific immune system modulation
08/30/1995EP0668770A1 $g(a)-SUBSTITUTED POLYPEPTIDES HAVING THERAPEUTIC ACTIVITY
08/30/1995EP0668766A1 Small molecule inhibition of rna/ligand binding
08/30/1995EP0668765A1 Characterization of a chromosome 11q23 translocation breakpoint associated with acute leukemias
08/30/1995EP0485577B1 Immunostimulant drug based on polar glycopeptidolipids of mycobacterium chelonae
08/30/1995EP0428541B1 Collagen wound healing matrices and process for their production
08/30/1995CN1107364A Pharmaceutical combination
08/30/1995CN1107363A Alcohol or aldehyde derivatives and their use
08/30/1995CN1107362A Tissue protective and regenerative compositions
08/29/1995US5446187 Antitumor agent
08/29/1995US5446161 Amino acid derivatives
08/29/1995US5446132 Thrombin-activated platelet protein-2 (TAPP-2)
08/29/1995US5446131 Polypeptides or cylic polypeptide; therapeutic and prophylactic; inhibit thrombin-induced platelet aggregation
08/29/1995US5446130 Polypeptide hormone inhibitor
08/29/1995US5446129 Peptide or its salt for autoimmune hyperthyroidism containing it
08/29/1995US5446091 Collagen-polymer conjugates containing an ether linkage
08/29/1995US5446070 Flexible, finite, bioadhesive, therapeutical agent in solid form
08/29/1995US5446026 Potent non-opiate analgesic
08/29/1995US5446025 Formulations and method of the percutaneous administration of leuprolide
08/29/1995US5446024 Reverse phase liquid chromatograghy
08/29/1995US5446022 Cyclic polypeptides; protozoicides and fungicides;
08/29/1995US5446020 Method of treating diabetes with tissue-selective insulin analogs
08/29/1995US5445960 Monoclonal antibodies specific for HIV and hybridomas for their production
08/29/1995US5445958 Process for purifying blood clotting factors
08/29/1995US5445957 Enzyme food supplement composition containing beta-fructofuranosidase, cellulase and hemicellulase
08/29/1995US5445940 Methods and compositions for detecting and treating a subset of human patients having an autoimmune disease
08/29/1995US5445832 Composition of sustained and controlled release of medicamentous peptide substances by converting water soluble peptide into a water insoluble peptide salt
08/29/1995US5445818 Synthetic pseudomonas aeruginosa pilin peptide vaccine and method of use
08/29/1995CA2059840C Composition for the treatment of diabetes
08/29/1995CA1336826C Chimeric antibody with specificity to human b cell surface antigen
08/29/1995CA1336825C Use and agent for reducing the side effects of tnf
08/29/1995CA1336817C Angiogenesis inhibitor
08/29/1995CA1336816C Wound healing
08/29/1995CA1336815C Method for preventing secondary effects
08/29/1995CA1336814C Reduction of low density lipoproteins in biological fluids
08/29/1995CA1336813C Urogenital sinus derived growth inhibitory factor
08/29/1995CA1336812C Human collagen processing and autoimplant use
08/29/1995CA1336810C Synergistic interplay of lymphokines and double stranded rnas
08/25/1995CA2143261A1 Method of diagnosing cancer, precancerous state, or susceptibility to other forms of diseases by analysis of irf-1-specific rna in biopsy samples
08/24/1995WO1995022625A1 Dna mutagenesis by random fragmentation and reassembly
08/24/1995WO1995022619A1 B7-1-specific ligands, and their use for the induction of t cell anergy
08/24/1995WO1995022617A1 Host-vector system for use in gene therapy
08/24/1995WO1995022614A1 Production of glycosylphosphatidylinositol-anchored recombinant proteins
08/24/1995WO1995022613A1 Tumor associated monoclonal antibody 123av16
08/24/1995WO1995022612A2 Genes and genetic elements associated with sensitivity to platinum-based drugs
08/24/1995WO1995022611A2 Methods and compositions for stimulating bone cells
08/24/1995WO1995022610A1 Novel integrin alpha subunit
08/24/1995WO1995022609A2 Human glutamate receptor proteins
08/24/1995WO1995022608A1 Galanin receptor, nucleic acids, transformed cells and uses thereof
08/24/1995WO1995022604A1 Rna editing enzyme and methods of use thereof
08/24/1995WO1995022603A1 Vaccine to control ectoparasites
08/24/1995WO1995022600A1 Ribozyme therapy for hepatitis b infection
08/24/1995WO1995022563A1 Antigenic preparation for treatment or prevention of helicobacter infection
08/24/1995WO1995022560A1 Pharmaceutical formulations of cntf
08/24/1995WO1995022559A1 Immunosuppressive compounds and method of preparing same
08/24/1995WO1995022558A1 Method for the preparation of glycopeptidic antibiotic precursors by intramolecular cyclisation and formation of a biaryl ether bridge and novel compounds so obtained
08/24/1995WO1995022557A1 Novel opioid peptides for the treatment of pain and use thereof
08/24/1995WO1995022350A1 Composition and method for preventing and treating inflammation with immunoglobulin a
08/24/1995WO1995022349A1 Verotoxin pharmaceutical compositions and medical treatments therewith
08/24/1995WO1995022348A1 Medical application of bromelain
08/24/1995WO1995022347A1 Pharmaceutical preparation containing plasminogen activators
08/24/1995WO1995022346A1 Use of ceruletide diethyl amine salt in the treatment of psoriasis
08/24/1995WO1995022345A1 A method and agents for control and management of labor during pregnancy
08/24/1995WO1995022344A1 Therapeutic use of myelin-associated glycoprotein (mag)
08/24/1995WO1995022343A1 Cyclosporin-containing emulsion composition
08/24/1995WO1995022342A1 Pharmaceutical formulations of ciliary neurotrophic factor
08/24/1995WO1995022341A1 Labelled peptide compounds
08/24/1995WO1995022340A1 Methods for altering fertility
08/24/1995WO1995022339A1 Cyclic heptapeptide anti-inflammatory agent
08/24/1995WO1995022338A1 Broad spectrum antimicrobial compounds and methods of use
08/24/1995WO1995022328A1 Treatment and/or prevention of type i diabetes mellitus with gamma interferon administration
08/24/1995WO1995022318A1 Drugs, vaccines and hormones in polylactide coated microspheres
08/24/1995WO1995022316A1 Biologic bioadhesive compositions containing fibrin glue and liposomes, methods of preparation and use
08/24/1995WO1995022249A1 Transgenic fibrinogen
08/24/1995WO1995019435A3 T cell antigen receptor v region proteins and methods of preparation thereof
08/24/1995WO1995013374A3 Human and mouse very low density lipoprotein receptors and methods for use of such receptors
08/24/1995DE4405426A1 Pharmazeutisches Präparat enthaltend Plasminogenaktivator (t-PA) oder dessen Derivate A pharmaceutical preparation containing plasminogen activator (t-PA) or derivatives thereof
08/24/1995DE19505287A1 Zusammensetzung und Verfahren zur Prävention und Behandlung von Entzündungen mit Immunglobulin A A composition and method for the prevention and treatment of inflammation with immunoglobulin A
08/24/1995CA2183866A1 Medical application of bromelain
08/24/1995CA2183680A1 B7-1-specific ligands, and their use for the induction of t cell anergy
08/24/1995CA2183630A1 Therapeutic use of myelin-associated glycoprotein (mag)
08/24/1995CA2183566A1 Composition and method for preventing and treating inflammation with immunoglobulin a
08/24/1995CA2183421A1 Labelled peptide compounds
08/24/1995CA2183333A1 Method for the preparation of glycopeptidic antibiotic precursors by intramolecular cyclisation and formation of a biaryl ether bridge and novel compounds so obtained
1 ... 2831 2832 2833 2834 2835 2836 2837 2838 2839 2840 2841 2842 2843 2844 2845 2846 2847 2848 2849 2850 2851 ... 3163